north london hospice
north london hospice Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
47 woodside avenue, london, N12 8TF
Website
www.northlondonhospice.orgnorth london hospice Estimated Valuation
Pomanda estimates the enterprise value of NORTH LONDON HOSPICE at £10.5m based on a Turnover of £15.3m and 0.69x industry multiple (adjusted for size and gross margin).
north london hospice Estimated Valuation
Pomanda estimates the enterprise value of NORTH LONDON HOSPICE at £14.1m based on an EBITDA of £2.7m and a 5.3x industry multiple (adjusted for size and gross margin).
north london hospice Estimated Valuation
Pomanda estimates the enterprise value of NORTH LONDON HOSPICE at £67.9m based on Net Assets of £28.9m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
North London Hospice Overview
North London Hospice is a live company located in london, N12 8TF with a Companies House number of 01654807. It operates in the other human health activities sector, SIC Code 86900. Founded in July 1982, it's largest shareholder is unknown. North London Hospice is a mature, mid sized company, Pomanda has estimated its turnover at £15.3m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
North London Hospice Health Check
Pomanda's financial health check has awarded North London Hospice a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
3 Weak
Size
annual sales of £15.3m, make it larger than the average company (£725k)
£15.3m - North London Hospice
£725k - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (7.2%)
-4% - North London Hospice
7.2% - Industry AVG
Production
with a gross margin of 38.6%, this company has a comparable cost of product (38.6%)
38.6% - North London Hospice
38.6% - Industry AVG
Profitability
an operating margin of 13.9% make it more profitable than the average company (5.1%)
13.9% - North London Hospice
5.1% - Industry AVG
Employees
with 239 employees, this is above the industry average (18)
239 - North London Hospice
18 - Industry AVG
Pay Structure
on an average salary of £48.6k, the company has a higher pay structure (£26.4k)
£48.6k - North London Hospice
£26.4k - Industry AVG
Efficiency
resulting in sales per employee of £64k, this is more efficient (£45.6k)
£64k - North London Hospice
£45.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - North London Hospice
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - North London Hospice
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - North London Hospice
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 75 weeks, this is less cash available to meet short term requirements (126 weeks)
75 weeks - North London Hospice
126 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.1%, this is a lower level of debt than the average (22.4%)
7.1% - North London Hospice
22.4% - Industry AVG
NORTH LONDON HOSPICE financials
North London Hospice's latest turnover from March 2024 is £15.3 million and the company has net assets of £28.9 million. According to their latest financial statements, North London Hospice has 239 employees and maintains cash reserves of £2.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 15,305,713 | 12,077,518 | 14,971,229 | 17,072,529 | 13,068,553 | 9,415,473 | 12,383,235 | 8,315,354 | 10,398,987 | 9,405,373 | 8,754,092 | 7,006,960 | 7,412,335 | 7,270,041 | 5,750,606 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | 1,613,677 | -2,972,003 | 2,620,315 | 6,486,251 | 403,676 | -1,565,004 | 2,221,147 | -1,662,905 | 1,138,915 | 979,006 | 605,881 | -281,579 | 208,323 | 988,380 | -204,287 |
| Tax | |||||||||||||||
| Profit After Tax | 1,613,677 | -2,972,003 | 2,620,315 | 6,486,251 | 403,676 | -1,565,004 | 2,221,147 | -1,662,905 | 1,138,915 | 979,006 | 605,881 | -281,579 | 208,323 | 988,380 | -204,287 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 1,613,677 | -2,972,003 | 2,620,315 | 6,486,251 | 403,676 | -1,565,004 | 2,221,147 | -1,662,905 | 1,138,915 | 979,006 | 605,881 | -281,579 | 208,323 | 988,380 | -204,287 |
| Employee Costs | 11,613,167 | 10,694,336 | 10,310,104 | 10,296,828 | 9,718,167 | 8,319,630 | 7,744,209 | 7,464,506 | 6,984,850 | 6,296,283 | 6,011,102 | 5,359,629 | 5,413,174 | 4,603,153 | 4,391,079 |
| Number Of Employees | 239 | 223 | 191 | 197 | 195 | 177 | 174 | 174 | 165 | 151 | 134 | 129 | 117 | 106 | 104 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 8,200,780 | 8,188,899 | 7,579,083 | 7,830,708 | 7,982,988 | 7,905,011 | 8,076,539 | 8,249,626 | 8,371,184 | 8,499,876 | 8,177,045 | 7,964,291 | 7,350,999 | 5,702,717 | 5,292,108 |
| Intangible Assets | |||||||||||||||
| Investments & Other | 16,726,231 | 15,050,286 | 15,268,084 | 13,911,240 | 11,370,939 | 11,694,034 | 10,557,623 | 11,868,381 | 10,129,590 | 10,362,491 | 9,409,873 | 9,409,023 | 8,703,978 | 8,926,646 | 9,258,793 |
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 24,927,011 | 23,239,185 | 22,847,167 | 21,741,948 | 19,353,927 | 19,599,045 | 18,634,162 | 20,118,007 | 18,500,774 | 18,862,367 | 17,586,918 | 17,373,314 | 16,054,977 | 14,629,363 | 14,550,901 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 3,705,934 | 3,885,289 | 7,194,996 | 5,951,344 | 3,211,858 | 1,898,988 | 4,224,706 | 1,406,120 | 2,833,513 | 2,753,485 | 1,687,603 | 904,917 | 1,026,939 | 676,889 | 561,488 |
| Cash | 2,490,316 | 3,262,544 | 2,901,546 | 2,700,003 | 2,060,072 | 3,016,423 | 2,065,504 | 1,276,212 | 1,449,147 | 253,543 | 779,943 | 779,720 | 1,042,850 | 2,458,684 | 1,221,940 |
| misc current assets | |||||||||||||||
| total current assets | 6,196,250 | 7,147,833 | 10,096,542 | 8,651,347 | 5,271,930 | 4,915,411 | 6,290,210 | 2,682,332 | 4,282,660 | 3,007,028 | 2,467,546 | 1,684,637 | 2,069,789 | 3,135,573 | 1,783,428 |
| total assets | 31,123,261 | 30,387,018 | 32,943,709 | 30,393,295 | 24,625,857 | 24,514,456 | 24,924,372 | 22,800,339 | 22,783,434 | 21,869,395 | 20,054,464 | 19,057,951 | 18,124,766 | 17,764,936 | 16,334,329 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,720,752 | 1,296,421 | 1,095,534 | 1,295,955 | 1,825,447 | 908,298 | 656,370 | 735,907 | 567,503 | 520,881 | 754,719 | 709,961 | 535,672 | 294,297 | 296,240 |
| total current liabilities | 1,720,752 | 1,296,421 | 1,095,534 | 1,295,955 | 1,825,447 | 908,298 | 656,370 | 735,907 | 567,503 | 520,881 | 754,719 | 709,961 | 535,672 | 294,297 | 296,240 |
| loans | 500,000 | 1,801,765 | 1,587,340 | 1,456,820 | 1,646,220 | 1,398,921 | 1,365,554 | 1,321,394 | 1,281,158 | 1,261,531 | 1,250,247 | 1,220,315 | 1,181,551 | 1,140,824 | 1,082,924 |
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 500,000 | 1,801,765 | 1,587,340 | 1,456,820 | 1,646,220 | 1,778,921 | 1,867,554 | 1,933,394 | 1,867,158 | 1,927,531 | 1,655,247 | 1,220,315 | 1,181,551 | 1,140,824 | 1,082,924 |
| total liabilities | 2,220,752 | 3,098,186 | 2,682,874 | 2,752,775 | 3,471,667 | 2,687,219 | 2,523,924 | 2,669,301 | 2,434,661 | 2,448,412 | 2,409,966 | 1,930,276 | 1,717,223 | 1,435,121 | 1,379,164 |
| net assets | 28,902,509 | 27,288,832 | 30,260,835 | 27,640,520 | 21,154,190 | 21,827,237 | 22,400,448 | 20,131,038 | 20,348,773 | 19,420,983 | 17,644,498 | 17,127,675 | 16,407,543 | 16,329,815 | 14,955,165 |
| total shareholders funds | 28,902,509 | 27,288,832 | 30,260,835 | 27,640,520 | 21,154,190 | 21,827,237 | 22,400,448 | 20,131,038 | 20,348,773 | 19,420,983 | 17,644,498 | 17,127,675 | 16,407,543 | 16,329,815 | 14,955,165 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 540,760 | 496,661 | 385,718 | 377,846 | 362,459 | 349,411 | 324,936 | 378,245 | 344,802 | 337,740 | 302,963 | 294,749 | 222,663 | 226,352 | 217,443 |
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | -179,355 | -3,309,707 | 1,243,652 | 2,739,486 | 1,312,870 | -2,325,718 | 2,818,586 | -1,427,393 | 80,028 | 1,065,882 | 782,686 | -122,022 | 350,050 | 115,401 | 561,488 |
| Creditors | |||||||||||||||
| Accruals and Deferred Income | 424,331 | 200,887 | -200,421 | -529,492 | 917,149 | 251,928 | -79,537 | 168,404 | 46,622 | -233,838 | 44,758 | 174,289 | 241,375 | -1,943 | 296,240 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -732,064 | -444,501 | 1,097,172 | -260,733 | -9,183 | -309,478 | -492,858 | -594,768 | -1,652,026 | 129,704 | -132,664 | ||||
| Change in Investments | 1,675,945 | -217,798 | 1,356,844 | 2,540,301 | -323,095 | 1,136,411 | -1,310,758 | 1,738,791 | -232,901 | 952,618 | 850 | 705,045 | -222,668 | -332,147 | 9,258,793 |
| cash flow from investments | -1,675,945 | 217,798 | -1,356,844 | -2,540,301 | -408,969 | -1,580,912 | 2,407,930 | -1,999,524 | 223,718 | -1,262,096 | -493,708 | -1,299,813 | -1,429,358 | 461,851 | -9,391,457 |
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -1,301,765 | 214,425 | 130,520 | -189,400 | 247,299 | 33,367 | 44,160 | 40,236 | 19,627 | 11,284 | 29,932 | 38,764 | 40,727 | 57,900 | 1,082,924 |
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | -1,301,765 | 214,425 | 130,520 | -189,321 | -829,424 | 1,025,160 | 92,423 | 1,485,406 | -191,498 | 808,763 | -59,126 | 1,040,475 | -89,868 | 444,170 | 16,242,376 |
| cash and cash equivalents | |||||||||||||||
| cash | -772,228 | 360,998 | 201,543 | 639,931 | -956,351 | 950,919 | 789,292 | -172,935 | 1,195,604 | -526,400 | 223 | -263,130 | -1,415,834 | 1,236,744 | 1,221,940 |
| overdraft | |||||||||||||||
| change in cash | -772,228 | 360,998 | 201,543 | 639,931 | -956,351 | 950,919 | 789,292 | -172,935 | 1,195,604 | -526,400 | 223 | -263,130 | -1,415,834 | 1,236,744 | 1,221,940 |
north london hospice Credit Report and Business Information
North London Hospice Competitor Analysis
Perform a competitor analysis for north london hospice by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in N12 area or any other competitors across 12 key performance metrics.
north london hospice Ownership
NORTH LONDON HOSPICE group structure
North London Hospice has 1 subsidiary company.
Ultimate parent company
NORTH LONDON HOSPICE
01654807
1 subsidiary
north london hospice directors
North London Hospice currently has 15 directors. The longest serving directors include Mr Simon Morris (Sep 2011) and Mr John Reid (Jul 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Simon Morris | 64 years | Sep 2011 | - | Director | |
| Mr John Reid | England | 50 years | Jul 2017 | - | Director |
| Mr Henry Easterling | 61 years | Jun 2019 | - | Director | |
| Mrs Beverley Taylor | 70 years | Jun 2019 | - | Director | |
| Mr Simon Males | 55 years | Mar 2020 | - | Director | |
| Dr Catherine Woodwark | 66 years | Apr 2020 | - | Director | |
| Mr Andrew Harris | United Kingdom | 62 years | Feb 2021 | - | Director |
| Dr Ujjal Sarkar | 45 years | Jan 2022 | - | Director | |
| Mrs Anna Bokobza | 42 years | Jan 2022 | - | Director | |
| Mr Saurabh Khare | 47 years | Jan 2022 | - | Director |
P&L
March 2024turnover
15.3m
+27%
operating profit
2.1m
0%
gross margin
38.7%
+2.08%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
28.9m
+0.06%
total assets
31.1m
+0.02%
cash
2.5m
-0.24%
net assets
Total assets minus all liabilities
north london hospice company details
company number
01654807
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
incorporation date
July 1982
age
43
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
north london hospice group (August 1993)
accountant
-
auditor
BUZZACOTT LLP
address
47 woodside avenue, london, N12 8TF
Bank
BARCLAYS BANK PLC
Legal Advisor
-
north london hospice Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to north london hospice. Currently there are 1 open charges and 1 have been satisfied in the past.
north london hospice Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NORTH LONDON HOSPICE. This can take several minutes, an email will notify you when this has completed.
north london hospice Companies House Filings - See Documents
| date | description | view/download |
|---|
